IMPACT OF ABDOMINAL OBESITY ON INCIDENCE OF ADVERSE METABOLIC EFFECTS ASSOCIATED WITH ANTIHYPERTENSIVE MEDICATIONS

We assessed adverse metabolic effects (AMEs) of atenolol and hydrochlorothiazide (HCTZ) among hypertensive patients with and without abdominal obesity using data from a randomized, open-label study of hypertensive patients without evidence of cardiovascular disease or diabetes. Intervention included...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cooper-DeHoff, Rhonda M., Wen, Sheron, Beitelshees, Amber L., Zineh, Issam, Gums, John G., Turner, Stephen T., Gong, Yan, Hall, Karen, Parekh, Vishal, Chapman, Arlene B., Boerwinkle, Eric, Johnson, Julie A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2811061/
https://ncbi.nlm.nih.gov/pubmed/19917874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.109.139592
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados